Have you ever wondered if you're getting the most out of genomic testing for gastric cancer?

In this animated video, molecular pathologist Prof. Frédéric Bibeau shares the guideline recommendations and best tips for precision oncology in gastric cancer, including:
• Relevant biomarkers and implications in gastric cancer
• Who, when, and how to order biomarker testing
• Techniques used for biomarker testing in gastric cancer
• Challenges and recommendations to reduce the limitations of testing and interpreting results

Find out more about the programme and see Prof. Frédéric Bibeau's key clinical takeaways: https://cor2ed.com/precision-oncology-connect/programmes/testing-prostate-cancer/?media=1

Clinical Takeaways:
• It is paramount to have enough samples to perform all the tests needed, starting with diagnosis
• Order the right biomarkers to help with treatment decision-making
• In gastric cancer, the use of IHC and ISH are the main techniques for precision medicine in 2024
• HER2 status, PD-L1 and MMR are crucial for treatment decisions in 2024

Follow PRECISION ONCOLOGY CONNECT on social media:
X
LinkedIn:  / ntrk-connect 

Published December 2024.

This content is intended for healthcare professionals only. The medical experts in this video are expressing their own views and not those of COR2ED, Supporters or their institution. This video is supported by an Independent Medical Education Grant from AstraZeneca and Amoy Diagnostics. This video is developed by https://cor2ed.com/